These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37096787)

  • 1. Latent heterogeneity of muscle-invasive bladder cancer in patient characteristics and survival: A population-based nation-wide study in the Bladder Cancer Data Base Sweden (BladderBaSe).
    Häggström C; Rowley M; Liedberg F; Coolen ACC; Holmberg L
    Cancer Med; 2023 Jun; 12(12):13856-13864. PubMed ID: 37096787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe).
    Aljabery F; Liedberg F; Häggström C; Ströck V; Hosseini A; Gårdmark T; Sherif A; Jerlström T; Malmström PU; Holmberg L; Hagberg O; Jahnson S
    Scand J Urol; 2019 Oct; 53(5):332-338. PubMed ID: 31663405
    [No Abstract]   [Full Text] [Related]  

  • 3. Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0.
    Häggström C; Hagberg O; Gårdmark T; Aljabery F; Ströck V; Hosseini A; Sherif A; Malmstrom PU; Söderkvist K; Ullén A; Jerlström T; Jahnson S; Liedberg F; Holmberg L
    BMJ Open; 2022 Dec; 12(12):e064898. PubMed ID: 36600418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment.
    Møller CT; Fosså SD; Tafjord G; Babigumira R; Berge V; Andreassen BK
    Scand J Urol; 2022 Jun; 56(3):214-220. PubMed ID: 35506475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe).
    Häggström C; Liedberg F; Hagberg O; Aljabery F; Ströck V; Hosseini A; Gårdmark T; Sherif A; Malmström PU; Garmo H; Jahnson S; Holmberg L
    BMJ Open; 2017 Sep; 7(9):e016606. PubMed ID: 28963292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014.
    Westergren DO; Gårdmark T; Lindhagen L; Chau A; Malmström PU
    J Urol; 2019 Nov; 202(5):905-912. PubMed ID: 31144594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study.
    Häggström C; Garmo H; de Luna X; Van Hemelrijck M; Söderkvist K; Aljabery F; Ströck V; Hosseini A; Gårdmark T; Malmström PU; Jahnson S; Liedberg F; Holmberg L
    Cancer Med; 2019 May; 8(5):2196-2204. PubMed ID: 30938068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Allocation and Survival in Patients Diagnosed with Nonmetastatic Muscle-invasive Bladder Cancer: An Analysis of a National Patient Cohort in England.
    John JB; Varughese MA; Cooper N; Wong K; Hounsome L; Treece S; McGrath JS; Harden S
    Eur Urol Focus; 2021 Mar; 7(2):359-365. PubMed ID: 32088138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study.
    Zheng Y; Ye Y; Chen J; Wei Z; Liu Z; Yu K; Zhang X
    Int J Surg; 2022 Jul; 103():106693. PubMed ID: 35690361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
    Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G
    Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival.
    Russell B; Sherif A; Häggström C; Josephs D; Kumar P; Malmström PU; Van Hemelrijck M
    Scand J Urol; 2019 Aug; 53(4):206-212. PubMed ID: 31174452
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic factors for survival in patients with recurrence of muscle invasive bladder cancer after treatment with curative intent.
    Ploeg M; Kums AC; Aben KK; van Lin EN; Smits G; Vergunst H; Viddeleer AC; Geboers AD; van Berkel H; van Boven E; Kiemeney LA; Witjes F
    Clin Genitourin Cancer; 2011 Sep; 9(1):14-21. PubMed ID: 21723794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of untreated muscle-invasive bladder cancer.
    Martini A; Sfakianos JP; Renström-Koskela L; Mortezavi A; Falagario UG; Egevad L; Hosseini A; Mehrazin R; Galsky MD; Steineck G; Wiklund NP
    BJU Int; 2020 Feb; 125(2):270-275. PubMed ID: 31310696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis.
    Chen J; Zhang H; Sun G; Zhang X; Zhao J; Liu J; Shen P; Shi M; Zeng H
    Int J Surg; 2018 Apr; 52():214-220. PubMed ID: 29496649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.
    Jerlström T; Chen R; Liedberg F; Andrén O; Ströck V; Aljabery FAS; Hosseini A; Sherif A; Malmström PU; Ullén A; Gårdmark T; Fall K
    World J Urol; 2020 Feb; 38(2):381-388. PubMed ID: 31020424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.
    Aziz A; Gierth M; Fritsche HM; May M; Otto W; Denzinger S; Wieland WF; Merseburger A; Riedmiller H; Kocot A; Burger M
    Urol Int; 2013; 91(1):97-102. PubMed ID: 23751372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe).
    Aljabery F; Liedberg F; Häggström C; Ströck V; Hosseini A; Gårdmark T; Sherif A; Jerlström T; Malmström PU; Hagberg O; Holmberg L
    BJU Int; 2020 Nov; 126(5):625-632. PubMed ID: 32762064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study.
    Nouhaud FX; Chakroun M; Lenormand C; Ouzaid I; Peyronnet B; Gryn A; Prudhomme T; Grafeille V; Soulié M; Roumiguié M; Verhoest G; Xylinas E; Bouzouita A; Chebil M; Pfister C
    Urol Oncol; 2021 Mar; 39(3):195.e1-195.e6. PubMed ID: 33214030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry.
    Richters A; Leliveld AM; Goossens-Laan CA; Aben KKH; Özdemir BC
    World J Urol; 2022 Sep; 40(9):2275-2281. PubMed ID: 35778577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.
    Fonteyne V; Ost P; Bellmunt J; Droz JP; Mongiat-Artus P; Inman B; Paillaud E; Saad F; Ploussard G
    Eur Urol; 2018 Jan; 73(1):40-50. PubMed ID: 28478043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.